# Neurofibromatosis Type 1 Tumor Early Detection Study

> **NCT06515860** · — · RECRUITING · sponsor: **David Miller** · enrollment: 1000 (estimated)

## Conditions studied

- Neurofibromatosis Type 1
- Neurofibromatosis 1
- Plexiform Neurofibroma
- Plexiform Neurofibromas
- Malignant Peripheral Nerve Sheath Tumor
- Malignant Peripheral Nerve Sheath Tumors
- Atypical Neurofibroma

## Interventions

- **DIAGNOSTIC_TEST:** Liquid biopsy for MPNST development

## Key facts

- **NCT ID:** NCT06515860
- **Lead sponsor:** David Miller
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-07
- **Primary completion:** 2030-07
- **Final completion:** 2030-07
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06515860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06515860, "Neurofibromatosis Type 1 Tumor Early Detection Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06515860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
